//www.koonmotors.com/news/health_medicine/blood_clots/ Read the latest news on blood clots, including prevention strategies and new treatments including research on blood thinners. en-us Sun, 10 Sep 2023 21:16:26 EDT Sun, 10 Sep 2023 21:16:26 EDT 60 //www.koonmotors.com/images/scidaily-logo-rss.png//www.koonmotors.com/news/health_medicine/blood_clots/ For more science news, visit ScienceDaily. //www.koonmotors.com/releases/2023/08/230829130007.htm Modern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45 percent compared to the traditional drug warfarin in the treatment of blood clots in the legs and lungs, according to a recent study. Tue, 29 Aug 2023 13:00:07 EDT //www.koonmotors.com/releases/2023/08/230829130007.htm //www.koonmotors.com/releases/2023/08/230821114401.htm Various medical circumstances, including heart attacks and extreme cases of COVID-19, necessitate the use of anticoagulants, medicines that prevent blood clots. But the most commonly used, heparin, can induce potentially fatal side effects by making the blood clots worse rather than better. This only happens in a minority of patients so effective treatments are not commonly explored. Researchers have now proposed a side effect-free anticoagulating treatment that has so far proved effective in test mice and could be ready for human trials in just a few years. Mon, 21 Aug 2023 11:44:01 EDT //www.koonmotors.com/releases/2023/08/230821114401.htm //www.koonmotors.com/releases/2023/08/230810110315.htm A new observation suggests that a life-threatening blood clotting disorder can be caused by an infection with adenovirus, one of the most common respiratory viruses in pediatric and adult patients. Thu, 10 Aug 2023 11:03:15 EDT //www.koonmotors.com/releases/2023/08/230810110315.htm //www.koonmotors.com/releases/2023/04/230413154235.htm 'Don't poke the bear', they said. But that's exactly what a team of scientists have been doing, to discover the secrets of blood clotting. Hibernating bears, paralysed humans, and pigs kept in small enclosures all avoid dangerous blood clots, despite being immobile for extremely long periods. Thu, 13 Apr 2023 15:42:35 EDT //www.koonmotors.com/releases/2023/04/230413154235.htm //www.koonmotors.com/releases/2023/03/230324093436.htm The glycoprotein V of the blood platelets is an important switch point for haemostasis and thrombus formation. This new finding could have great clinical potential. Fri, 24 Mar 2023 09:34:36 EDT //www.koonmotors.com/releases/2023/03/230324093436.htm //www.koonmotors.com/releases/2023/03/230302093408.htm Being overweight in childhood and in early adulthood are discrete risk factors for blood clots later in life, a University of Gothenburg study shows. The study is based on the early BMI history of more than 37,000 men and information about their thrombi, if any, in adulthood. Thu, 02 Mar 2023 09:34:08 EST //www.koonmotors.com/releases/2023/03/230302093408.htm //www.koonmotors.com/releases/2023/01/230123123313.htm Researchers have developed a new tool and technique that uses 'vortex ultrasound' -- a sort of ultrasonic tornado -- to break down blood clots in the brain. The new approach worked more quickly than existing techniques to eliminate clots formed in an in vitro model of cerebral venous sinus thrombosis (CVST). Mon, 23 Jan 2023 12:33:13 EST //www.koonmotors.com/releases/2023/01/230123123313.htm //www.koonmotors.com/releases/2023/01/230118195700.htm Patients hospitalized with fractures typically receive an injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots. A new clinical trial, however, found that inexpensive over-the-counter aspirin is just as effective. Wed, 18 Jan 2023 19:57:00 EST //www.koonmotors.com/releases/2023/01/230118195700.htm //www.koonmotors.com/releases/2023/01/230111164425.htm Researchers combined heparin with a protein fragment, peptide, to slow down the release of the drug and convey the medication directly to the site of a clot. Wed, 11 Jan 2023 16:44:25 EST //www.koonmotors.com/releases/2023/01/230111164425.htm //www.koonmotors.com/releases/2022/12/221213094827.htm Researchers who identified a novel mechanism for platelet activation in pathogenic blood clotting (thrombosis) are now turning their attention to sepsis. Tue, 13 Dec 2022 09:48:27 EST //www.koonmotors.com/releases/2022/12/221213094827.htm //www.koonmotors.com/releases/2022/11/221107083315.htm A new study could change the treatment course for hundreds of thousands of patients, saving lives and preventing complications. Mon, 07 Nov 2022 08:33:15 EST //www.koonmotors.com/releases/2022/11/221107083315.htm //www.koonmotors.com/releases/2022/11/221103104941.htm Researchers have discovered a new role for the blood clotting protein, von Willebrand Factor (VWF), that could lead to the development of new treatments for patients with inflammatory and blood clotting disorders. Thu, 03 Nov 2022 10:49:41 EDT //www.koonmotors.com/releases/2022/11/221103104941.htm //www.koonmotors.com/releases/2022/09/220919122115.htm When patients who are on a commonly prescribed blood thinner stop taking aspirin, their risk of bleeding complications drops significantly (more than 30%), a new study finds. Researchers say aspirin should only be taken under the direction of a physician to review if the expected benefit outweighs the risk. Mon, 19 Sep 2022 12:21:15 EDT //www.koonmotors.com/releases/2022/09/220919122115.htm //www.koonmotors.com/releases/2022/09/220914205335.htm Obese women who use oral contraceptives containing estrogen and progestin have a 24-fold increased risk of venous thromboembolism (VTE) compared with non-obese women not using the drugs, according to a new article. Wed, 14 Sep 2022 20:53:35 EDT //www.koonmotors.com/releases/2022/09/220914205335.htm //www.koonmotors.com/releases/2022/08/220823095434.htm New research has provided greater insight into the causes of Long COVID syndrome. The findings further investigate the link between Long COVID and blood clotting. Tue, 23 Aug 2022 09:54:34 EDT //www.koonmotors.com/releases/2022/08/220823095434.htm //www.koonmotors.com/releases/2022/08/220804102545.htm A study from a COVID-19 cohort reveals an additional link between the immune system and blood clots, which could improve the treatment of critical illnesses. Thu, 04 Aug 2022 10:25:45 EDT //www.koonmotors.com/releases/2022/08/220804102545.htm //www.koonmotors.com/releases/2022/08/220803120356.htm Researchers report on a novel function of vitamin K, which is generally known for its importance in blood clotting. The researchers discovered that the fully reduced form of vitamin K acts as an antioxidant efficiently inhibiting ferroptotic cell death. Wed, 03 Aug 2022 12:03:56 EDT //www.koonmotors.com/releases/2022/08/220803120356.htm //www.koonmotors.com/releases/2022/06/220610140856.htm Around one in 500 men could be carrying an extra X or Y chromosome -- most of them unaware -- putting them at increased risk of diseases such as type 2 diabetes, atherosclerosis and thrombosis, say researchers. Fri, 10 Jun 2022 14:08:56 EDT //www.koonmotors.com/releases/2022/06/220610140856.htm //www.koonmotors.com/releases/2022/05/220503102850.htm This was the first time a blood clot had been found in an astronaut in space, so there was no established method of treatment for DVT in zero gravity. Tue, 03 May 2022 10:28:50 EDT //www.koonmotors.com/releases/2022/05/220503102850.htm //www.koonmotors.com/releases/2022/04/220413104208.htm A new study suggests that people with cancer and non-O blood types, such as types A, B, and AB, face an increased risk of developing venous thromboembolism (VTE), or blood clots in the veins, three months after their initial diagnosis. Scientists have long strived to understand the risk factors for VTE, the leading cause of preventable hospital deaths in the United States. Existing assessments use factors like tumor or cancer type to detect those at high risk of VTE. Yet, many patients without these diagnoses still develop life-threatening blood clots but go unidentified. Wed, 13 Apr 2022 10:42:08 EDT //www.koonmotors.com/releases/2022/04/220413104208.htm //www.koonmotors.com/releases/2022/03/220311141419.htm New research has revealed new information about how blood clots are formed during wound healing. Fri, 11 Mar 2022 14:14:19 EST //www.koonmotors.com/releases/2022/03/220311141419.htm //www.koonmotors.com/releases/2022/02/220217131916.htm Scientists have discovered that 'rogue' antibodies found circulating in the blood of COVID-19 patients have the potential to cause endothelial cells to lose their resistance to clotting. These antiphospholipid autoantibodies can trigger blood clots in the arteries and veins of patients with autoimmune disorders, including lupus and antiphospholipid syndrome. The findings provide an even stronger connection between autoantibody formation and clotting in COVID-19. Thu, 17 Feb 2022 13:19:16 EST //www.koonmotors.com/releases/2022/02/220217131916.htm //www.koonmotors.com/releases/2022/02/220211102615.htm Cerebral venous thrombosis is a rare, often severe disease that has been brought to public attention by the COVID-19 pandemic. A research group has now succeeded for the first time in deciphering a molecular cause of this disease. This opens the way to new therapeutic approaches. Fri, 11 Feb 2022 10:26:15 EST //www.koonmotors.com/releases/2022/02/220211102615.htm //www.koonmotors.com/releases/2022/01/220128141330.htm Patients with COVID-19 in the intensive care unit (ICU) prescribed full-dose blood thinners are significantly more likely to experience heavy bleeding than patients prescribed a smaller yet equally effective dose, according to a recent study. Fri, 28 Jan 2022 14:13:30 EST //www.koonmotors.com/releases/2022/01/220128141330.htm //www.koonmotors.com/releases/2022/01/220126143951.htm Biomedical researchers report that their latest innovation in developing synthetic platelets could help save lives by rapidly stabilizing clots to reduce blood loss from traumatic injuries. This new effort centers on the creation of next-generation, platelet-mimicking nanoparticles that help generate a protein mesh that acts as a natural netting to stabilize blood clots and help stop bleeding. If proven safe and efficient in clinical trials, the technology would bolster the scientists' advances in a decade-long effort to develop and optimize what they call synthetic platelet surrogates. Wed, 26 Jan 2022 14:39:51 EST //www.koonmotors.com/releases/2022/01/220126143951.htm //www.koonmotors.com/releases/2022/01/220119194301.htm Take breaks when binge-watching TV to avoid blood clots, say scientists. The warning comes as a study reports that watching TV for four hours a day or more is associated with a 35% higher risk of blood clots compared with fewer than 2.5 hours. Wed, 19 Jan 2022 19:43:01 EST //www.koonmotors.com/releases/2022/01/220119194301.htm //www.koonmotors.com/releases/2021/12/211221162723.htm Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists showed that artificial intelligence (AI) algorithms can detect signs of these clots in electrocardiograms (EKGs), a finding which may one day help doctors with screening. Tue, 21 Dec 2021 16:27:23 EST //www.koonmotors.com/releases/2021/12/211221162723.htm //www.koonmotors.com/releases/2021/12/211209082555.htm Two complementary studies show that defibrotide can successfully suppress the formation and progression of neutrophil extracellular traps, or NETs, which are web-like networks of toxic proteins that play a role in forming blood clots and promoting inflammation in several disease, including COVID-19. Researchers say findings may set the stage for defibrotide clinical trials in potentially several diseases. Thu, 09 Dec 2021 08:25:55 EST //www.koonmotors.com/releases/2021/12/211209082555.htm //www.koonmotors.com/releases/2021/12/211207152557.htm Treatment targeting immune-regulating neutrophil activation may reduce pathological thrombosis in COVID-19 patients, researchers report. Tue, 07 Dec 2021 15:25:57 EST //www.koonmotors.com/releases/2021/12/211207152557.htm //www.koonmotors.com/releases/2021/12/211206220025.htm Researchers have found a new marker in the blood of COVID-19 patients. The finding provides insights into the course and development of the disease and could lead to better diagnoses. Mon, 06 Dec 2021 22:00:25 EST //www.koonmotors.com/releases/2021/12/211206220025.htm //www.koonmotors.com/releases/2021/11/211115123506.htm Researchers compared milvexian with enoxaparin for prevention of blood clots in 1,242 patients from 18 countries undergoing knee replacement surgery who were enrolled between June 2019 and February 2021. They found that at a total daily dose of 100 mg or more, milvexian resulted in better clot protection but no increase in bleeding compared with enoxaparin, the control drug. Milvexian was evaluated in daily doses ranging from 25 to 400 mg; there was no increase in bleeding over this wide range of doses. Mon, 15 Nov 2021 12:35:06 EST //www.koonmotors.com/releases/2021/11/211115123506.htm //www.koonmotors.com/releases/2021/11/211112122548.htm Clotting problems and resulting complications are common in COVID-19 patients. Researchers have now shown that a member of the anticoagulant group of drugs not only has a beneficial effect on survival of COVID-19 patients, but also influences the duration of active infection with the SARS-CoV-2 coronavirus. 星期五,2021年11月12日12:25:48 EST //www.koonmotors.com/releases/2021/11/211112122548.htm //www.koonmotors.com/releases/2021/10/211025101714.htm Lipopolysaccharide, a virulence factor produced by bacteria, is a toxin that can cause a systemic inflammation via the circulation. In a recently completed study, genetic markers were discovered which are associated with a heightened lipopolysaccharide level in the blood. Mon, 25 Oct 2021 10:17:14 EDT //www.koonmotors.com/releases/2021/10/211025101714.htm //www.koonmotors.com/releases/2021/10/211020083859.htm People at risk from strokes and heart attacks could benefit from personalized clotting profiles to help clinicians prescribe more precise treatments, thanks to new research. Wed, 20 Oct 2021 08:38:59 EDT //www.koonmotors.com/releases/2021/10/211020083859.htm //www.koonmotors.com/releases/2021/09/210909124440.htm The presence of special immune system defense molecules, called autoimmune antibodies, has been strongly tied to how poorly people fare when hospitalized with COVID-19, a new study shows. Thu, 09 Sep 2021 12:44:40 EDT //www.koonmotors.com/releases/2021/09/210909124440.htm //www.koonmotors.com/releases/2021/09/210908180540.htm Abnormal crosstalk between blood platelets and cells lining blood vessels is one cause of deadly organ damage in patients with severe COVID-19, a new study finds. Wed, 08 Sep 2021 18:05:40 EDT //www.koonmotors.com/releases/2021/09/210908180540.htm //www.koonmotors.com/releases/2021/08/210830140237.htm 基于g决定一个人的血型enetic tests instead of merely traditional blood tests can provide a better picture of the risk of cardiovascular diseases. If a patient has two genetic variants of A, B or AB, the risk is twice as high compared with if one is O. Mon, 30 Aug 2021 14:02:37 EDT //www.koonmotors.com/releases/2021/08/210830140237.htm //www.koonmotors.com/releases/2021/08/210816125717.htm New evidence shows that patients with Long COVID syndrome continue to have higher measures of blood clotting, which may help explain their persistent symptoms, such as reduced physical fitness and fatigue. Mon, 16 Aug 2021 12:57:17 EDT //www.koonmotors.com/releases/2021/08/210816125717.htm //www.koonmotors.com/releases/2021/07/210727212832.htm A new study of cells shows that antibodies produced by the body in response to COVID-19 may be triggering a blood clotting response in patients with severe disease. Tue, 27 Jul 2021 21:28:32 EDT //www.koonmotors.com/releases/2021/07/210727212832.htm //www.koonmotors.com/releases/2021/07/210719110545.htm A potentially game-changing treatment for people with, or at risk of, blood clots has been found effective by an international team of researchers. Mon, 19 Jul 2021 11:05:45 EDT //www.koonmotors.com/releases/2021/07/210719110545.htm //www.koonmotors.com/releases/2021/07/210716112446.htm A scientific review has found evidence that a disruption in blood clotting and the first line immune system could be contributing factors in the development of psychosis. Fri, 16 Jul 2021 11:24:46 EDT //www.koonmotors.com/releases/2021/07/210716112446.htm //www.koonmotors.com/releases/2021/07/210715124532.htm Researchers set out to develop technology capable of localizing and imaging blood clots in deep veins. Turns out their work may not only identify blood clots, but it may also be able to treat them. Thu, 15 Jul 2021 12:45:32 EDT //www.koonmotors.com/releases/2021/07/210715124532.htm //www.koonmotors.com/releases/2021/07/210713184404.htm 新的研究表明,管理一个完整的剂量of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. Tue, 13 Jul 2021 18:44:04 EDT //www.koonmotors.com/releases/2021/07/210713184404.htm //www.koonmotors.com/releases/2021/06/210615132119.htm Scientists have identified how and why some COVID-19 patients can develop life-threatening clots, which could lead to targeted therapies that prevent this from happening. Tue, 15 Jun 2021 13:21:19 EDT //www.koonmotors.com/releases/2021/06/210615132119.htm //www.koonmotors.com/releases/2021/06/210607202208.htm Understanding the physics of clot contraction could potentially lead to new ways to treat bleeding problems and clotting problems. Mon, 07 Jun 2021 20:22:08 EDT //www.koonmotors.com/releases/2021/06/210607202208.htm //www.koonmotors.com/releases/2021/06/210601135716.htm 一种新的微型人类骨髓的3 d模型just been described. The model may help clinicians predict which patients will benefit from a new therapy for blood platelet disorders, such as Inherited Thrombocytopenias -- a group of familial disorders that inhibit the production of platelets. It could also enable further study of these disorders and give scientists a new tool to test experimental treatments. Tue, 01 Jun 2021 13:57:16 EDT //www.koonmotors.com/releases/2021/06/210601135716.htm //www.koonmotors.com/releases/2021/05/210518130819.htm Researchers used a technique in genetic analysis termed Mendelian randomization to examine 12 coagulation measures, uncovering four that are associated with migraine susceptibility. Tue, 18 May 2021 13:08:19 EDT //www.koonmotors.com/releases/2021/05/210518130819.htm //www.koonmotors.com/releases/2021/05/210517102624.htm A rare syndrome has been observed in people following vaccination against COVID-19. This involves thrombosis at unusual sites in the body, associated with a low thrombocyte count and a clotting disorder. In medical jargon, this syndrome is referred to as VITT (vaccine-induced thrombotic thrombocytopenia). Doctors at MedUni Vienna and Vienna General Hospital have now successfully treated an acute instance of this syndrome. Mon, 17 May 2021 10:26:24 EDT //www.koonmotors.com/releases/2021/05/210517102624.htm //www.koonmotors.com/releases/2021/05/210515134656.htm Researchers are reporting the first instance of COVID-19 triggering a rare recurrence of potentially serious blood clots in people's arms. Sat, 15 May 2021 13:46:56 EDT //www.koonmotors.com/releases/2021/05/210515134656.htm //www.koonmotors.com/releases/2021/04/210428080936.htm Scientists have identified the specific structural element of von Willebrand Factor that allows it to bind with platelets and initiate blood clotting. The team says that the specific unit, which they call the discontinuous autoinhibitory module, or AIM, is a prime site for new drug development. Wed, 28 Apr 2021 08:09:36 EDT //www.koonmotors.com/releases/2021/04/210428080936.htm //www.koonmotors.com/releases/2021/04/210419135711.htm 对于一些病人来说,dding aspirin to a direct oral anticoagulant is an equation that rarely adds up. Mon, 19 Apr 2021 13:57:11 EDT //www.koonmotors.com/releases/2021/04/210419135711.htm //www.koonmotors.com/releases/2021/02/210217134845.htm Researchers have developed a new tool for addressing disseminated intravascular coagulation (DIC) - a blood disorder that proves fatal in many patients. The technology has not yet entered clinical trials, but in vivo studies using rat models and in vitro models using blood from DIC patients highlight the tech's potential. Wed, 17 Feb 2021 13:48:45 EST //www.koonmotors.com/releases/2021/02/210217134845.htm //www.koonmotors.com/releases/2021/02/210215092439.htm Aspirin should be favoured over warfarin to prevent blood clotting in children who undergo a surgery that replumbs their hearts, according to a new study. Mon, 15 Feb 2021 09:24:39 EST //www.koonmotors.com/releases/2021/02/210215092439.htm //www.koonmotors.com/releases/2021/01/210107125246.htm Engineering researchers have developed a new technique for eliminating particularly tough blood clots, using engineered nanodroplets and an ultrasound 'drill' to break up the clots from the inside out. The technique has not yet gone through clinical testing. In vitro testing has shown promising results. Thu, 07 Jan 2021 12:52:46 EST //www.koonmotors.com/releases/2021/01/210107125246.htm //www.koonmotors.com/releases/2021/01/210105104826.htm Brain metastases can only develop if cancer cells exit the capillaries and enter into the brain tissue. To facilitate this step, cancer cells influence blood clotting, as scientists have now been able to show in mice. The cancer cells actively promote the formation of clots, which helps them to arrest in the brain capillaries and then penetrate through the vessel wall. Drugs that inhibit thrombin were able to reduce the number of brain metastases. Tue, 05 Jan 2021 10:48:26 EST //www.koonmotors.com/releases/2021/01/210105104826.htm //www.koonmotors.com/releases/2020/11/201123134422.htm While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with an increased tendency of the blood to clot, leading to a higher risk of death from COVID-19. Mon, 23 Nov 2020 13:44:22 EST //www.koonmotors.com/releases/2020/11/201123134422.htm //www.koonmotors.com/releases/2020/11/201116092142.htm The RIVER trial is the largest study assessing the efficacy and safety of the anticoagulant rivaroxaban in patients with an artificial mitral valve to correct an irregular heart rhythm. Researchers concluded that rivaroxaban worked as well as the standard anticoagulant medication warfarin. Mon, 16 Nov 2020 09:21:42 EST //www.koonmotors.com/releases/2020/11/201116092142.htm //www.koonmotors.com/releases/2020/11/201102142254.htm A new study reveals that COVID-19 triggers production of antibodies circulating through the blood, causing clots in people hospitalized with the disease. Mon, 02 Nov 2020 14:22:54 EST //www.koonmotors.com/releases/2020/11/201102142254.htm //www.koonmotors.com/releases/2020/10/201001113553.htm A new review provides an in-depth analysis of the risk of venous thromboembolism (VTE) in patients hospitalized for COVID-19. While hospitalized patients at general wards have a VTE risk of between 5 and 11 percent, the risk of developing deep vein thrombosis or pulmonary embolism in critically ill patients is 18 to 28 percent. Thu, 01 Oct 2020 11:35:53 EDT //www.koonmotors.com/releases/2020/10/201001113553.htm //www.koonmotors.com/releases/2020/09/200908131122.htm New research points to disturbances in blood clotting protein factor V activity as both a potential cause of blood clotting disorders with COVID-19, and to potential methods for identifying at-risk patients with the goal of selecting the proper anticoagulation therapy. Tue, 08 Sep 2020 13:11:22 EDT //www.koonmotors.com/releases/2020/09/200908131122.htm